Latest Content

Raising Awareness for Kidney Cancer and the Challenges Patients Face

April 7th 2025, 8:00pm

By Sid Salder

Video

It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.

Shorter Radiation Courses May Improve Breast Reconstruction Outcomes

April 7th 2025, 7:00pm

By Dr. Reshma Jagsi

Video

Shorter radiation courses may improve breast reconstruction outcomes without increasing complications, according to Dr. Reshma Jagsi.

How ‘Man in the Mirror’ Reflects a Cancer Journey

April 7th 2025, 5:00pm

By Joe Bullock

Article

I always wanted to make a difference, but I never expected my biggest impact to come through cancer.

BELLA Clinical Trial Initiated in Platinum-Resistant Ovarian Cancer

April 7th 2025, 3:00pm

By Alex Biese

Article

The BELLA phase 2 clinical trial of relacorilant plus nab-paclitaxel and Avastin among patients with platinum-resistant ovarian cancer has been launched.

How Biomarker Testing Can Shape a Breast Cancer Treatment Plan

April 7th 2025, 1:00pm

By Andy Guinigundo

Video

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

Raising Awareness for Lymphedema Following a Cancer Diagnosis

April 6th 2025, 6:00pm

By Ryan Scott

Article

Dr. Sheri Yolanda Prentiss explores the challenges patients face in accessing lymphedema compression garments following cancer treatment.

FDA Grants HLX22 Orphan Drug Designation for Gastric Cancer

April 6th 2025, 2:00pm

By Spencer Feldman

Article

FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free survival and objective response.

Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away

April 5th 2025, 6:00pm

By Dr. Zachariah H. Foda

Video

Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.

Personalized Cancer Vaccine Generates Responses Across Cancer Types

April 5th 2025, 2:00pm

By Ryan Scott

Article

PGV001, a personalized cancer vaccine, induced immune responses across various cancer types like breast and urothelial cancer, as well as multiple myeloma.

Understanding the Use of Bispecific Antibodies in Multiple Myeloma

April 4th 2025, 9:00pm

By Ryan Scott

Article

Bispecific antibodies target specific cells, offering effective treatment for relapsed/refractory multiple myeloma, with varying side effect profiles.

How Personalized Medicine May Impact Gastrointestinal Cancer Treatment

April 4th 2025, 8:00pm

By Dr. Valerie Lee

Video

Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.

Overcoming Challenges and Advancing CAR-T Therapy for Myeloma

April 4th 2025, 7:00pm

By Spencer Feldman

Article

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, despite strong efficacy in trials.

The Miniature Zen Garden: A Useful Tool for Those Dealing with Cancer

April 4th 2025, 5:00pm

By Laura Yeager

Article

I tried using a Zen garden that helped me meditate and relax while dealing with the challenges of cancer, and it really works.

FDA Grants Breakthrough Therapy to IDE196 in Primary Uveal Melanoma

April 4th 2025, 4:06pm

By Ryan Scott

Article

The FDA granted Breakthrough Therapy designation to IDE196 for the neoadjuvant treatment of primary uveal melanoma when enucleation has been recommended.

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

April 4th 2025, 3:12pm

By Ryan Scott

Article

The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.